PeerJSynthetic BiologyPeer-reviewed journal article
A Synthetic Defective Interfering SARS-CoV-2
Shun YaoiD, Anoop NarayananiD, Sydney A. MajowicziD, Joyce JoseiD, Marco ArchettiiD
Abstract
Viruses thrive by exploiting the cells they infect but must also produce viral proteins to replicate and infect other cells. As a consequence, they are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses, and even replicate faster due to its shorter size, interfering with the replication of the virus. We have created a synthetic defective interfering version of SARS-CoV-2, the virus causing the recent Covid-19 pandemic, assembling parts of the viral genome that do not code for any functional protein but enable it to be replicated and packaged. This synthetic defective genome replicates three times faster than SARS-CoV-2 in coinfected cells, and interferes with it, reducing the viral load of a cell by half in 24 hours. The synthetic genome is transmitted as efficiently as the full-length genome, confirming the location of the putative packaging signal of SARS-CoV-2. A version of such a synthetic construct could be used as a self-promoting antiviral therapy: by enabling replication of the synthetic genome, the virus promotes its own demise. O_FIG O_LINKSMALLFIG WIDTH=153 HEIGHT=200 SRC="FIGDIR/small/393587v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@60aa77org.highwire.dtl.DTLVardef@57a965org.highwire.dtl.DTLVardef@132574dorg.highwire.dtl.DTLVardef@18e2e_HPS_FORMAT_FIGEXP M_FIG Graphic summary C_FIG
- Citations
- 22
- FWCI
- 1.27
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A scalable pipeline for SARS-CoV-2 replicon construction based on de-novo synthesis
Ahmet Can Berkyurek, Elian Lee, … Yaniv Erlich·bioRxiv·Feb 5, 2022
- Exploring the therapeutic potential of defective interfering particles in reducing the replication of SARS-CoV-2
M. Locke, D. Grebennikov, … C. Molina-Paris·MathematicsPeer-reviewed·Jun 19, 2024
- Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection
Y. Rao, T.-Y. Wang, … P. Feng·bioRxiv·Feb 5, 2021
- Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
Lipika R. Pal, Kuoyuan Cheng, … Eytan Ruppin·iSciencePeer-reviewed·Apr 27, 2022
- Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection
T. Zhou, N. J. Gilliam, … Y. Sun·bioRxiv·Sep 22, 2022
- Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication in vitro through stimulation of innate immunity
U. Rand, S. Y. Kupke, … D. Bruder·bioRxiv·Feb 19, 2021